Cargando…
Distinctive detection of insulinoma using [(18)F]FB(ePEG12)12-exendin-4 PET/CT
Specifying the exact localization of insulinoma remains challenging due to the lack of insulinoma-specific imaging methods. Recently, glucagon-like peptide-1 receptor (GLP-1R)-targeted imaging, especially positron emission tomography (PET), has emerged. Although various radiolabeled GLP-1R agonist e...
Autores principales: | Murakami, Takaaki, Fujimoto, Hiroyuki, Hamamatsu, Keita, Yamauchi, Yuki, Kodama, Yuzo, Fujita, Naotaka, Fujikura, Junji, Shimizu, Yoichi, Nakamoto, Yuji, Kimura, Hiroyuki, Saji, Hideo, Inagaki, Nobuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298522/ https://www.ncbi.nlm.nih.gov/pubmed/34294854 http://dx.doi.org/10.1038/s41598-021-94595-6 |
Ejemplares similares
-
(18)F-labeled PEGylated exendin-4 imaging noninvasively differentiates insulinoma from an accessory spleen: the first case report of [18F]FB(ePEG12)12-exendin-4 positron emission tomography/computed tomography for insulinoma
por: Sakaki, Kentaro, et al.
Publicado: (2023) -
First-in-Human Evaluation of Positron Emission Tomography/Computed Tomography With [(18)F]FB(ePEG12)12-Exendin-4: A Phase 1 Clinical Study Targeting GLP-1 Receptor Expression Cells in Pancreas
por: Fujimoto, Hiroyuki, et al.
Publicado: (2021) -
Investigation of the preservation effect of canagliflozin on pancreatic beta cell mass using SPECT/CT imaging with (111)In-labeled exendin-4
por: Hamamatsu, Keita, et al.
Publicado: (2019) -
Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects
por: Murakami, Takaaki, et al.
Publicado: (2020) -
Hypoglycemia Unawareness in Insulinoma Revealed with Flash Glucose Monitoring Systems
por: Sugawa, Taku, et al.
Publicado: (2018)